Get Patent Opposition Report for Aptevo Biotherapeutics

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Aptevo Biotherapeutics against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2295547Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein ExpressionBAXALTAJun 18, 2018